FBS-ASaP: Fibrobronchoscopy in ASpiration Pneumonia in the Emergency Department
FBS-ASaP
1 other identifier
observational
100
1 country
1
Brief Summary
Non-Profit Prospective Observational Pilot Study The study will have an overall duration of 3 years, with patient enrollment starting after ethical committee approval. In this study, all patients with a diagnosis of aspiration pneumonia who require aspiration of secretions or ingesta in the Emergency Department will be considered. A registry will be created with the patients\' data, noting the type of procedure performed: laryngotracheal aspiration with a probe or with fibrobronchoscopy. This observational registry pilot study aims to evaluate the utility and adverse events related to the use of aspiration via videobronchoscopy performed in the Emergency Department and to compare the clinical outcomes of patients undergoing bronchoscopy with those treated only with blind laryngotracheal aspiration using a probe.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2024
CompletedFirst Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
July 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 5, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 5, 2027
July 22, 2024
July 1, 2024
3 years
July 10, 2024
July 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Length of hospital stay in days
Length of hospital stay in days
up to 3 months
Mortality rate within 30 days from the time of admission to the Emergency Department
Mortality rate within 30 days from the time of admission to the Emergency Department
30 days from admission to the ed
Secondary Outcomes (4)
Respiratory parameters before and after the procedure
on the admission and 30 minutes after the procedure
Rate of patient treated with Non invase ventilation and with orotracheal intubation
on the admission and 30 minutes after the procedure
Rate of admission in Intensive care unit and High dependency unit
immediately after the procedure
Procedure-related complications
perioperatively/periprocedurally
Study Arms (2)
Laryngotracheal Aspiration Procedure Using a Probe in the Emergency Department
Patients with aspiration pneumonia. For laryngotracheal aspiration using a blind probe, the patient will be positioned in a seated or semi-seated position; if this is not possible, the aspiration will be performed in a supine position. A soft, sterile catheter connected to the suction apparatus will be inserted into one nostril while keeping the patient's head tilted back. When the tip of the catheter reaches the back of the pharynx, the patient will need to breathe to facilitate the insertion and allow the catheter to advance into the larynx and trachea. At this point, using negative suction pressure for a maximum of 3-5 seconds, the secretions will be aspirated. The aspiration will be repeated multiple times in cycles of 3-5 seconds.
Aspiration Using Fibrobronchoscopy in the Emergency Department
Patients with aspiration pneumonia. The bronchoscope will be gently inserted through the patient's nostril or mouth, advancing carefully through the pharynx and larynx into the trachea and bronchi. The physician will visually inspect the airways through the bronchoscope. Using the bronchoscope's suction channel, secretions will be aspirated from the trachea and bronchi. Suctioning will be performed intermittently to avoid hypoxia, with each suctioning cycle lasting no more than 3-5 seconds. The procedure may be repeated as necessary to ensure thorough aspiration of secretions.
Interventions
For laryngotracheal aspiration using a blind probe, the patient will be positioned in a seated or semi-seated position; if this is not possible, the aspiration will be performed in a supine position. A soft, sterile catheter connected to the suction apparatus will be inserted into one nostril while keeping the patient\'s head tilted back. When the tip of the catheter reaches the back of the pharynx, the patient will need to breathe to facilitate the insertion and allow the catheter to advance into the larynx and trachea. At this point, using negative suction pressure for a maximum of 3-5 seconds, the secretions will be aspirated. The aspiration will be repeated multiple times in cycles of 3-5 seconds.
Equipment Setup: A sterile bronchoscope will be connected to the suction apparatus. Procedure: The bronchoscope will be gently inserted through the patient\'s nostril or mouth, advancing carefully through the pharynx and larynx into the trachea and bronchi. The physician will visually inspect the airways through the bronchoscope. Using the bronchoscope's suction channel, secretions will be aspirated from the trachea and bronchi. Suctioning will be performed intermittently to avoid hypoxia, with each suctioning cycle lasting no more than 3-5 seconds. The procedure may be repeated as necessary to ensure thorough aspiration of secretions.
Eligibility Criteria
The study will be conducted on patients with a diagnosis of aspiration pneumonia who, based on the judgment of the attending physician, require aspiration of secretions or ingesta in the emergency department using a probe and/or a fiberscope. Enrollment in the study will be determined by the Emergency Department physician in charge of the patient. Estimated number of patients to be enrolled: 100.
You may qualify if:
- All adult patients who access the Emergency Department with a diagnosis of aspiration pneumonia and for whom the referring physician determines the need for aspiration of secretions or ingesta. Patients must have at least one of the following criteria
- Radiological evidence of pneumonia (Chest X-ray/CT scan/Chest ultrasound)
- Clinical diagnosis of aspiration pneumonia
- Presence of secretions in the upper airways
- Respiratory distress in a dysphagic patient
- Need for oxygen therapy or need to increase FiO2 in patients already on home oxygen therapy
You may not qualify if:
- Lack of consent
- Age \< 18 years
- Pregnancy
- Hemorrhagic diathesis
- Malignant cardiac arrhythmias (VT, AV block excluding first-degree AV block)
- Severe airway obstruction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AOU Careggi
Florence, Tuscany/Italy, 50122, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lorenzo Pelagatti, dr
University of Florence
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 10, 2024
First Posted
July 22, 2024
Study Start
February 5, 2024
Primary Completion (Estimated)
February 5, 2027
Study Completion (Estimated)
March 5, 2027
Last Updated
July 22, 2024
Record last verified: 2024-07